{"sentence": "Antacids containing aluminum hydroxide and <e1> magnesium hydroxide </e1> reduce the oral absorption of <e2> enoxacin </e2> by 75%.", "relation": "1", "e1": "magnesium hydroxide", "e2": "enoxacin", "evs": ""}
{"sentence": "Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, <e1> disopyramide </e1> , quinine, amiodarone, <e2> quinidine </e2> , warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;", "relation": "0", "e1": "disopyramide", "e2": "quinidine", "evs": ""}
{"sentence": "Cyclosporine, Digoxin, Methotrexate <e1> Lodine </e1> , like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, <e2> digoxin </e2> , methotrexate, and increased toxicity.", "relation": "1", "e1": "Lodine", "e2": "digoxin", "evs": ""}
{"sentence": "Binding to Serum Proteins: The following agents may either inhibit <e1> levothyroxine sodium </e1> binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, <e2> perphenazine </e2> , phenylbutazone, phenytoin, salicylates, tamoxifen.", "relation": "1", "e1": "levothyroxine sodium", "e2": "perphenazine", "evs": ""}
{"sentence": "As with other <e1> antipsychotic agents </e1> , it should be noted that HALDOL may be capable of potentiating CNS depressants such as anesthetics, <e2> opiates </e2> , and alcohol.", "relation": "1", "e1": "antipsychotic agents", "e2": "opiates", "evs": ""}
{"sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as <e1> NUROMAX </e1> include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, <e2> lincomycin </e2> , clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.", "relation": "1", "e1": "NUROMAX", "e2": "lincomycin", "evs": ""}
{"sentence": "<e1> Netilmicin </e1> should not be administered concomitantly with potent loop diuretics such as <e2> furosemide </e2> and ethacrynic acid as the potential for ototoxicity is enhanced by the combination.", "relation": "0", "e1": "Netilmicin", "e2": "furosemide", "evs": ""}
{"sentence": "Therefore, co-administration of bupropion with drugs that are metabolized by CYP2D6 isoenzyme including certain antidepressants (e.g., nortriptyline, imipramine, desipramine, paroxetine, fluoxetine, sertraline), antipsychotics (e.g., haloperidol, risperidone, thioridazine), beta-blockers (e.g., <e1> metoprolol </e1> ), and Type 1C antiarrhythmics (e.g., propafenone, <e2> flecainide </e2> ), should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication.", "relation": "0", "e1": "metoprolol", "e2": "flecainide", "evs": ""}
{"sentence": "These drugs include the thiazides and other <e1> diuretics </e1> , corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, <e2> phenytoin </e2> , nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.", "relation": "0", "e1": "diuretics", "e2": "phenytoin", "evs": ""}
{"sentence": "Oral doses of <e1> Antizol </e1> (10-20 mg/kg), via alcohol dehydrogenase inhibition, significantly reduced the rate of elimination of <e2> ethanol </e2> (by approximately 40%) given to healthy volunteers in moderate doses.", "relation": "1", "e1": "Antizol", "e2": "ethanol", "evs": ""}
{"sentence": "Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and Lodine ( <e1> etodolac </e1> capsules and tablets) results in reduced protein binding of <e2> warfarin </e2> , but there was no change in the clearance of free warfarin.", "relation": "0", "e1": "etodolac", "e2": "warfarin", "evs": ""}
{"sentence": "There have been reports of interactions of <e1> erythromycin </e1> with carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, cisapride, disopyramide, lovastatin, <e2> bromocriptine </e2> , valproate, terfenadine, and astemizole.", "relation": "0", "e1": "erythromycin", "e2": "bromocriptine", "evs": ""}
{"sentence": "Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, <e1> Sporanox </e1> ), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline ( <e2> Theo-Dur </e2> ), and vitamin C.", "relation": "0", "e1": "Sporanox", "e2": "Theo-Dur", "evs": ""}
{"sentence": "- <e1> Lithium </e1> : Generally should not be given with <e2> diuretics </e2> .", "relation": "0", "e1": "Lithium", "e2": "diuretics", "evs": ""}
{"sentence": "Quinolones, including cinoxacin, may enhance the effects of oral <e1> anticoagulants </e1> , such as <e2> warfarin </e2> or its derivatives.", "relation": "0", "e1": "anticoagulants", "e2": "warfarin", "evs": ""}
{"sentence": "The effects of medicinal products with similar properties such as inotropes milrinone, enoximone, <e1> amrinone </e1> , olprinone and cilostazol may be exacerbated by <e2> anagrelide </e2> .", "relation": "1", "e1": "amrinone", "e2": "anagrelide", "evs": ""}
{"sentence": "Quinidine: Immediate Release Capsules: There have been rare reports of an interaction between <e1> quinidine </e1> and <e2> nifedipine </e2> (with a decreased plasma level of quinidine).", "relation": "1", "e1": "quinidine", "e2": "nifedipine", "evs": ""}
{"sentence": "Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain <e1> narcotic analgesics </e1> such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and <e2> antihistamines </e2> .", "relation": "0", "e1": "narcotic analgesics", "e2": "antihistamines", "evs": ""}
{"sentence": "Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, <e1> Tegretol </e1> , Trileptal, Topamax, Felbatol), antifungals ( <e2> Gris-PEG </e2> , Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.", "relation": "0", "e1": "Tegretol", "e2": "Gris-PEG", "evs": ""}
{"sentence": "In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( <e1> efavirenz </e1> , nevirapine, phenytoin, dexamethasone, or carbamazepine) with <e2> CANCIDAS </e2> may result in clinically meaningful reductions in caspofungin concentrations.", "relation": "1", "e1": "efavirenz", "e2": "CANCIDAS", "evs": ""}
{"sentence": "Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), <e1> sparfloxacin </e1> , grepafloxacin, <e2> guanethidine </e2> , guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.", "relation": "0", "e1": "sparfloxacin", "e2": "guanethidine", "evs": ""}
{"sentence": "Additionally, anti-malarial drugs, such as <e1> chloroquine </e1> and mefloquine, may antagonize the activity of <e2> carbamazepine </e2> .", "relation": "1", "e1": "chloroquine", "e2": "carbamazepine", "evs": ""}
{"sentence": "Iron Supplements and Foods Fortified With Iron Concomitant administration of <e1> cefdinir </e1> with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental <e2> iron </e2> reduced extent of absorption by 80% and 31%, respectively.", "relation": "1", "e1": "cefdinir", "e2": "iron", "evs": ""}
{"sentence": "In vitro studies have shown <e1> CASODEX </e1> can displace coumarin anticoagulants, such as <e2> warfarin </e2> , from their protein-binding sites.", "relation": "0", "e1": "CASODEX", "e2": "warfarin", "evs": ""}
{"sentence": "These increased exposures of <e1> norethindrone </e1> and ethinyl estradiol should be taken into consideration when selecting an oral <e2> contraceptive </e2> for women taking valdecoxib.", "relation": "0", "e1": "norethindrone", "e2": "contraceptive", "evs": ""}
{"sentence": "<e1> Physostigmine </e1> pretreatment augmented the depressant effect of <e2> alcohol </e2> on the early components P1 and N1, while attenuating alcohol's influence on components P2 and P3.", "relation": "1", "e1": "Physostigmine", "e2": "alcohol", "evs": ""}
{"sentence": "Warfarin: The effects of <e1> warfarin </e1> and <e2> NSAIDs </e2> on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone.", "relation": "1", "e1": "warfarin", "e2": "NSAIDs", "evs": ""}
{"sentence": "In another study with intravenous administration of <e1> midazolam </e1> , Aprepitant was given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, and midazolam 2 mg IV was given prior to the administration of the 3-day regimen of <e2> Aprepitant </e2> and on Days 4, 8, and 15.", "relation": "0", "e1": "midazolam", "e2": "Aprepitant", "evs": ""}
{"sentence": "Benzodiazepines: Combination <e1> hormonal contraceptives </e1> may decrease the clearance of some benzodiazepines (alprazolam, <e2> chlordiazepoxide </e2> , diazepam) and increase the clearance of others (lorazepam, oxazepam, temazepam).", "relation": "1", "e1": "hormonal contraceptives", "e2": "chlordiazepoxide", "evs": ""}
{"sentence": "The pharmacokinetics of <e1> naltrexone </e1> and its major metabolite <e2> 6-beta-naltrexol </e2> were unaffected following co-administration with Acamprosate.", "relation": "0", "e1": "naltrexone", "e2": "6-beta-naltrexol", "evs": ""}
{"sentence": "Coadministration of <e1> propoxyphene </e1> decreased the maximum plasma concentration of <e2> alprazolam </e2> by 6%, decreased clearance by 38%, and increased half-life by 58%.", "relation": "1", "e1": "propoxyphene", "e2": "alprazolam", "evs": ""}
{"sentence": "Protease inhibitors: Amprenavir, lopinavir, nelfinavir, and <e1> ritonavir </e1> have been shown to decrease plasma levels of <e2> combination hormonal contraceptives </e2> ;", "relation": "1", "e1": "ritonavir", "e2": "combination hormonal contraceptives", "evs": ""}
